Dergiler / The Anatolian Journal of Cardiology / 2018 / Cilt: 20 - Sayı: 4

microRNA-29a inhibits cardiac fibrosis in Sprague-Dawley rats by downregulating the expression of DNMT3A

Sayfa
198–205
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The expression levels of CollA1, α-SMA, and DNMT3A in the model groupwere significantly higher than those in the control group (p<0.05).Conclusion: miR-29a reduced the activation and proliferation of CFs to improve cardiac fibrosis probably by the downregulation of DNMT3A.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aims to investigate the effect of miR-29a targeting the regulation of DNMT3A on the development of cardiac fibrosis inSprague-Dawley (SD) rats.Methods: In vivo experiment: SD rats were randomly divided into model and control groups.
📊
Temel Bulgular & Veri:The expression levels of miR-29a, CollA1, α-SMA, andDNMT3A in the myocardium of each group were detected.
💡
Sonuç & Katkı:The expression levels of CollA1, α-SMA, and DNMT3A in the model groupwere significantly higher than those in the control group (p<0.05).Conclusion: miR-29a reduced the activation and proliferation of CFs to improve cardiac fibrosis probably by the downregulation of DNMT3A.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: This study aims to investigate the effect of miR-29a targeting the regulation of DNMT3A on the development of cardiac fibrosis inSprague-Dawley (SD) rats.Methods: In vivo experiment: SD rats were randomly divided into model and control groups. The cardiac and left ventricular indices in eachgroup were calculated. The pathological changes of the myocardium were observed. The expression levels of miR-29a, CollA1, α-SMA, andDNMT3A in the myocardium of each group were detected. In vitro experiment: The cardiac fibroblasts (CFs) of SD rats were isolated from themyocardial tissue of SD rats and cultured. The miR-29a mimics, inhibitors, DNMT3A-siRNA, and control-siRNA were transfected into CFs. Theexpression levels of miR-29a, DNMT3A, CollA1, and α-SMA were detected, and the proliferation of CFs after transfection was observed.Results: The heart weight index of the rats in the model group increased significantly compared with that in the control group. Obvious collagendeposition was observed in the myocardial tissue of the model group. The expression levels of CollA1, α-SMA, and DNMT3A in the model groupwere significantly higher than those in the control group (p<0.05).Conclusion: miR-29a reduced the activation and proliferation of CFs to improve cardiac fibrosis probably by the downregulation of DNMT3A.

🔖

Bu Makaleye Atıf Yap

QIN, R. H., TAO, H., NI, S. H., SHI, P., DAI, C., SHI, K. H. (2018). microRNA-29a inhibits cardiac fibrosis in Sprague-Dawley rats by downregulating the expression of DNMT3A. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 4, 198–205. https://ajindex.com/articles/358601

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Nagpal V, Rai R, Place AT, Murphy SB, Verma SK, Ghosh AK, Vaughan DE: MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation 2016; 133: 291-301
  2. Gupta SS, Zeglinski MR, Rattan SG, Landry NM, Ghavami S, Wigle JT, et al. Inhibition of autophagy inhibits the conversion of cardiacfibroblasts to cardiac myofibroblasts. Oncotarget 2016; 7: 78516-31
  3. Ng KM, Mok PY, Butler AW, Ho JC, Choi SW, Lee YK, et al. Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor. Circulation 2016; 134:1373-89
  4. Tao H, Yang JJ, Chen ZW, Xu SS, Zhou X, Zhan HY, et al. DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology 2014; 323: 42-50
  5. Pan X, Chen Z, Huang R, Yao Y, Ma G. Transforming Growth Factor β1, Induces the Expression of Collagen Type I by DNA Methylation in Cardiac Fibroblasts. PLoS One 2013; 8: e60335
  6. Jjingo D, Conley AB, Yi SV, Lunyak VV, Jordan IK. On the presence and role of human gene-body DNA methylation. Oncotarget 2012; 3: 462-74
  7. He M, Fan J, Jiang R, Tang WX, Wang ZW. Expression of DNMTs and genomic DNA methylation in gastric signet ring cell carcinoma. Mol Med Rep 2013; 8: 942-8
  8. Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R. Expression of DNA methyltransferases inbreast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer 2013; 16: 23-31
  9. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, et al. miR-141 and miR-29a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011; 17: 1627-35
  10. Zhang Z, Shen S. Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study. Medicine (Baltimore) 2017; 96: e8795
  11. Liu S, Zhang X, Hu C, Wang Y, Xu C. miR-29a inhibits human retinoblastoma progression by targeting STAT3. Oncol Rep 2018; 39: 739- 46
  12. Catanzaro G, Sabato C, Russo M, Rosa A, Abballe L, Besharat ZM, et al. Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs). Int J Mol Sci 2017; 18. pii: E2742
  13. Ning JZ, Li W, Cheng F, Yu WM, Rao T, Ruan Y, et al. MiR-29a Suppresses Spermatogenic Cell Apoptosis in Testicular Ischemia-Reperfusion Injury by Targeting TRPV4 Channels. Front Physiol 2017; 8: 966. 14